STOCK TITAN

Sharps Technology (STSS) Director Receives 100K Options Under 2025 Plan

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Robert M. Hayes, a director of Sharps Technology Inc. (ticker shown as STSS), reported a securities transaction on a Form 4. The filing records an option (right to buy) for 100,000 shares with a price of $6.41. The transaction line shows the option entry dated 08/22/2025 and indicates the shares were acquired (code A) and are held directly. The filing notes the grant was made under the Company’s 2025 Equity Incentive Plan and that the option will be 100% vested as of the issuance date. The form includes an earliest-transaction date of 12/04/2024 and a signature dated 08/26/2025.

Positive

  • Director alignment with shareholders: Grant of equity-based compensation under the 2025 Equity Incentive Plan aligns director incentives with stock performance
  • Immediate vesting stated: The option is described as 100% vested as of issuance, removing future service-condition uncertainty

Negative

  • Potential dilution: 100,000 options increase potential share count if exercised
  • Limited detail on plan terms: Filing does not state full expiration or exercisability timeline beyond the dated entry, limiting modeling precision

Insights

TL;DR: Director received a fully vested equity option grant under the 2025 plan; standard governance disclosure.

The Form 4 documents a director-level equity grant to Robert M. Hayes for 100,000 options at an exercise price of $6.41, granted under the company’s 2025 Equity Incentive Plan and described as 100% vested on issuance. As a governance matter, this is a routine insider disclosure showing alignment of director compensation with equity incentives. The filing provides clear ownership and vesting information but does not include additional context such as grant valuation, plan share pool impact, or any performance conditions.

TL;DR: Insiders acquired 100,000 options at $6.41; disclosure is material for share count and potential dilution tracking.

This Form 4 reports acquisition of 100,000 option rights by a director at an indicated price of $6.41. The options are granted under the 2025 Equity Incentive Plan and are fully vested at issuance, meaning they are immediately exercisable subject to plan terms. For investors and modelers, the key quantifiable items are the option quantity and strike, which affect potential dilution and exercise proceeds if exercised. The filing lacks explicit expiration or exercisability timeline details beyond the dated line entry, so further plan documents would be needed to model full dilution and timing impacts.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hayes Robert Michael

(Last) (First) (Middle)
C/O SHARPS TECHNOLOGY, INC.
105 MAXESS ROAD, STE. 124

(Street)
MELVILLE NY 11747

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Sharps Technology Inc. [ STSS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/04/2024
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Option (right to buy) 08/22/2025 P 100,000 A $6.41 100,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Granted pursuant to the Company's 2025 Equity Incentive Plan. The option will become 100% vested as of the issuance date.
/s/ Robert M. Hayes 08/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Robert M. Hayes report on the Form 4 for Sharps Technology Inc. (STSS)?

He reported an acquisition of an option (right to buy) for 100,000 shares at a price of $6.41, granted under the 2025 Equity Incentive Plan.

Is the option reported by the director vested?

Yes. The filing explicitly states the option will be 100% vested as of the issuance date.

When are the transaction and signature dates shown on the Form 4?

The form lists an earliest transaction date of 12/04/2024, an option line dated 08/22/2025, and a signature date of 08/26/2025.

Under what plan was the option granted?

The option was granted under the company’s 2025 Equity Incentive Plan as stated in the Remarks section.

How does this filing affect potential dilution?

The filing shows 100,000 option rights outstanding for the reporting person; if exercised, these options would increase outstanding shares and thus could dilute current shareholders.
Sharps Technology Inc

NASDAQ:STSSW

STSSW Rankings

STSSW Latest News

STSSW Latest SEC Filings

STSSW Stock Data

8.81M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
MELVILLE